Exzeo (XZO) stock drops nearly 8% in New Year trading — what investors are watching next
2 January 2026
1 min read

Exzeo (XZO) stock drops nearly 8% in New Year trading — what investors are watching next

NEW YORK, Jan 2, 2026, 14:20 ET — Regular session

  • Exzeo shares fell about 8% in afternoon trading, far underperforming the broader market.
  • Insurance and insurance-software names were mixed, with some peers also lower.
  • Focus turns to rate expectations and next week’s U.S. labor-market data, alongside Exzeo’s next quarterly update.

Shares of Exzeo Group Inc slid on Friday, down $1.89, or about 7.8%, at $22.36 in afternoon trading. The NYSE-listed stock traded between $22.25 and $24.18, with about 164,000 shares changing hands.

The move stood out on a relatively calm tape, as U.S. equities wobbled into the first full session of 2026 and investors reset positioning after year-end. Thin liquidity in newer listings can amplify swings even when the broader market is steady.

Exzeo, founded in 2012, provides software and analytics tools that help property-and-casualty insurers streamline tasks such as underwriting and claims. The company went public in November at $21 a share, and parent HCI Group retained an 81.5% stake, Reuters reported. 1

In the broader market, the SPDR S&P 500 ETF was off about 0.1%, while the Invesco QQQ was down about 0.4%. The SPDR S&P Insurance ETF fell about 1.2%; HCI Group shares were down about 4.2%, and Guidewire Software slid about 5.7%, while Lemonade gained about 6.5%.

Exzeo’s most recent SEC filing, dated Dec. 22, disclosed a Rule 10b5-1 plan by Chief Executive Paresh Patel to acquire up to 100,000 shares or $2 million of stock, whichever comes first. A 10b5-1 plan is a pre-set trading program that can allow insiders to buy or sell shares on a schedule, helping avoid the appearance of trading on material nonpublic information.

The company last reported quarterly results on Dec. 10, saying managed premium rose 142% year-on-year to $1.2 billion and revenue climbed 90% to $55.2 million for the quarter ended Sept. 30. Exzeo also said a fifth insurance company joined its platform in the third quarter, with a sixth joining in the fourth. 2

Macro remains part of the backdrop for growth and “fintech-adjacent” names, including insurance software providers, as investors weigh how far and how fast borrowing costs might move in 2026. “The next Fed Chair is probably going to be much more dovish than Jerome Powell,” said Dennis Dick, chief market strategist at Stock Trader Network — dovish meaning more inclined to cut rates to support growth.

For traders in XZO, Friday’s chart left the $22 area in focus after the stock tested that level intraday. A bounce back toward the $24 handle would retrace much of the day’s decline, while a break below Friday’s low would put the next support level to the test.

The stock’s pullback also lands at the start of a data-heavy stretch for markets, when rate expectations can shift quickly. That matters for newer listings where ownership is still settling and daily volume can be uneven.

Next week’s calendar includes a run of U.S. labor-market updates, culminating in the monthly employment report on Jan. 9, according to the Bureau of Labor Statistics schedule.

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
XRP fell about 5% Saturday to $1.42, extending a 22% weekly drop as thin liquidity and macro jitters drove sharp swings. Bitcoin rebounded above $70,000 after a brief plunge, while ether surged 12%. Ripple outlined plans for an “Institutional DeFi” roadmap, including a new lending protocol and permissioned DEX. The Federal Reserve held rates steady last week, with officials signaling caution on inflation.
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session
Previous Story

Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session

Corcept Therapeutics (CORT) stock rebounds today after FDA setback — here’s what investors are watching next
Next Story

Corcept Therapeutics (CORT) stock rebounds today after FDA setback — here’s what investors are watching next

Go toTop